Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Globus Medical Inc.

    NYSE: GMED · Real-Time Price · USD
    58.36
    0.17 (0.29%)
    At close: Jun 26, 2025, 11:17 AM

    Globus Medical Statistics

    Share Statistics

    Globus Medical has 135.38M shares outstanding. The number of shares has increased by 18.45% in one year.

    Shares Outstanding

    n/a
    		 135.38M

    Shares Change (YoY)

    n/a
    		 18.45%

    Shares Change (QoQ)

    n/a
    		 17.48%

    Owned by Institutions (%)

    n/a
    		 80.36%

    Shares Floating

    n/a
    		 134.43M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,210

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 5.16M, so 3.81% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.16M

    Short % of Shares Out

    n/a
    		 3.81%

    Short % of Float

    n/a
    		 5.12%

    Short Ratio (days to cover)

    n/a
    		 3.02

    Valuation Ratios

    The PE ratio is 109.01 and the forward PE ratio is 15.82. Globus Medical's PEG ratio is -3.6.

    PE Ratio

    n/a
    		 109.01

    Forward PE

    n/a
    		 15.82

    PS Ratio

    n/a
    		 4.46

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 2.69

    P/FCF Ratio

    n/a
    		 27.7

    PEG Ratio

    n/a
    		 -3.6
    Financial Ratio History

    Enterprise Valuation

    Globus Medical has an Enterprise Value (EV) of 10.98B.

    EV / Sales

    n/a
    		 4.36

    EV / EBITDA

    n/a
    		 28.97

    EV / EBIT

    n/a
    		 21.09

    EV / FCF

    n/a
    		 27.09

    Financial Position

    The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.13.

    Current Ratio

    n/a
    		 2.54

    Quick Ratio

    n/a
    		 1.77

    Debt / Equity

    n/a
    		 0.13

    Debt / EBITDA

    n/a
    		 1.42

    Debt / FCF

    n/a
    		 1.33

    Interest Coverage

    n/a
    		 39.63

    Financial Efficiency

    Return on Equity is 2.47% and Return on Invested Capital is 2.92%.

    Return on Equity

    n/a
    		 2.47%

    Return on Assets

    n/a
    		 1.96%

    Return on Invested Capital

    n/a
    		 2.92%

    Revenue Per Employee

    n/a
    		 $475,350

    Profits Per Employee

    n/a
    		 $19,430.94

    Employee Count

    n/a
    		 5,300

    Asset Turnover

    n/a
    		 0.48

    Inventory Turnover

    n/a
    		 1.57

    Taxes

    Income Tax

    n/a
    		 17.74M

    Effective Tax Rate

    n/a
    		 14.69%

    Stock Price Statistics

    The stock price has increased by -14.4% in the last 52 weeks. The beta is 1.21, so Globus Medical's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.21

    52-Week Price Change

    n/a
    		 -14.4%

    50-Day Moving Average

    n/a
    		 63.65

    200-Day Moving Average

    n/a
    		 75.14

    Relative Strength Index (RSI)

    n/a
    		 39.73

    Average Volume (20 Days)

    n/a
    		 1,446,640

    Income Statement

    In the last 12 months, Globus Medical had revenue of 2.52B and earned 102.98M in profits. Earnings per share was 0.76.

    Revenue

    n/a
    		 2.52B

    Gross Profit

    n/a
    		 1.48B

    Operating Income

    n/a
    		 165.99M

    Net Income

    n/a
    		 102.98M

    EBITDA

    n/a
    		 378.94M

    EBIT

    n/a
    		 219.7M

    Earnings Per Share (EPS)

    n/a
    		 0.76
    Full Income Statement

    Balance Sheet

    The company has 784.44M in cash and 537.19M in debt, giving a net cash position of 247.25M.

    Cash & Cash Equivalents

    n/a
    		 784.44M

    Total Debt

    n/a
    		 537.19M

    Net Cash

    n/a
    		 247.25M

    Retained Earnings

    n/a
    		 1.15B

    Total Assets

    n/a
    		 4.71B

    Working Capital

    n/a
    		 1.33B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 520.64M and capital expenditures -115.43M, giving a free cash flow of 405.21M.

    Operating Cash Flow

    n/a
    		 520.64M

    Capital Expenditures

    n/a
    		 -115.43M

    Free Cash Flow

    n/a
    		 405.21M

    FCF Per Share

    n/a
    		 2.99
    Full Cash Flow Statement

    Margins

    Gross margin is 58.9%, with operating and profit margins of 6.59% and 4.09%.

    Gross Margin

    n/a
    		 58.9%

    Operating Margin

    n/a
    		 6.59%

    Pretax Margin

    n/a
    		 4.79%

    Profit Margin

    n/a
    		 4.09%

    EBITDA Margin

    n/a
    		 15.04%

    EBIT Margin

    n/a
    		 6.59%

    FCF Margin

    n/a
    		 16.08%

    Dividends & Yields

    GMED does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.92%

    FCF Yield

    n/a
    		 3.61%
    Dividend Details

    Analyst Forecast

    The average price target for GMED is $95.5, which is 63.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $95.5

    Price Target Difference

    n/a
    		 63.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 14
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $3.8

    Lynch Upside

    n/a
    		 -93.48%

    Graham Number

    n/a
    		 22.92

    Graham Upside

    n/a
    		 -60.66%

    Scores

    Altman Z-Score

    n/a
    		 9.05

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist